Share

Her2+ cardiotoxicity

Her2+ Cardiotoxicity - An exploratory pilot study of cardiotoxicity induced by old and new generation anticancer drugs in patients with breast cancer.

Project objectives

Exploratory pilot study of cardiotoxicity induced by old and new generation anticancer drugs in patients with breast cancer.

Start and end date

May 2013 - June 2014

Project Manager

Prof. Germano Di Sciascio - Principal Investigator

Dr. S. Di Maria - Study Coordinator

Coordinating institution of the project

Università Campus Bio-Medico di Roma

QUICK LINKS
[] magnifiercrossmenuchevron-downchevron-leftchevron-right